Search Market Research Report
Diabetes Disposable Insulin Pen Market Size, Share Global Analysis Report, 2020–2026
Diabetes Disposable Insulin Pen Market By Type (Type 1 Diabetes and Type 2 Diabetes) and By Distribution Channel (Hospitals, Clinics, Chemists, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecast 2020–2026
Industry Insights
The Diabetes Disposable Insulin Pen market report analyzes and notifies the industry statistics at the global as well as regional and country levels to acquire a thorough perspective of the entire Diabetes Disposable Insulin Pen market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.
This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the Diabetes Disposable Insulin Pen industry. The report analyzes and declares the historical and current trends analysis of the Diabetes Disposable Insulin Pen industry and subsequently recommends the projected trends anticipated to be observed in the Diabetes Disposable Insulin Pen market during the upcoming years.
Key Insights from Primary Research
- As per our primary respondents, the Diabetes Disposable Insulin Pen market is set to grow annually at a rate of around 5.2%.
- It was established through primary research that the Diabetes Disposable Insulin Pen market was valued at around USD 9.5 billion in 2019.
- After secondary research, we performed face-to-face interviews to validate our data. The insights interviewees declared that Type 1 Diabetes patients are more likely to use Diabetes Disposable Insulin Pens.
- On the basis of the Sales Channel, Chemist dominated the global Diabetes Disposable Insulin Pen market in 2019. It accounted for around 27% share of the total market in 2019.
- The Type 1 diabetes category, on the basis of type segmentation, was the leading revenue-generating category accounting for around 68% share, in 2019.
Key Recommendations from Analysts
- Based on the exhaustive secondary research done by our team, the Chemists are anticipated to become the most demanding sales channel in the upcoming years, owing to the growing demand for Diabetes Disposable Insulin Pen combined with rising awareness amongst the population regarding diabetes and diabetes insulin pen.
- As per our analysts, North America recorded the highest market share of more than 34% by 2026, and the market is expected to bolster in this region, resulting in creating lucrative opportunities for new players.
- Growing at a CAGR of around 5.2%, the Diabetes Disposable Insulin Pen market provides numerous opportunities for all of the involved stakeholders across the entire value chain.
- Our analysts have identified type 1 diabetes and chemist categories as the leading investment pockets for the Diabetes Disposable Insulin Pen market in terms of type and sales channel segmentation respectively.
- Our analysts recommend the emerging players focus on chemist-based sales channels owing to the substantial growth of the pharmaceutical industry, especially in APAC and Middle-eastern regions.
Market Attractiveness – By Type
The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Diabetes Disposable Insulin Pen industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.
Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Diabetes Disposable Insulin Pen industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Diabetes Disposable Insulin Pen market.
The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Diabetes Disposable Insulin Pen industry. The Diabetes Disposable Insulin Pen market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.
The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Diabetes Disposable Insulin Pen sector. Key strategic developments in the Diabetes Disposable Insulin Pen market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Diabetes Disposable Insulin Pen market are appropriately highlighted in the report.
Diabetes Disposable Insulin Pen market was accounted for approximately USD 9.5 billion in 2019. The market is anticipated to grow at a CAGR of 5.2% and is anticipated to reach around USD 16.8 billion by 2026.
Diabetes is becoming increasingly common throughout the world. The increasing incidence of type I and type II diabetes, especially in decrepit old populations, increases the demand for insulin medication. In addition, data provided by the World Bank show that diabetes was prevalent in around 11% of the total US population and 9.2% of the global population in 2019. Despite these factors, the demand for disposable insulin stalks is projected to rise at a significant pace in the years ahead.
In addition, disposable insulin types are developed in such a way that newly diagnosed individuals, as well as elderly people, can use them. The use of insulin pens ensures the same dose of insulin and improves the delivery process. In addition, rising demand for insulin self-management, ease of use, and a lower risk of contamination with disposable insulin plumes are some of the factors that are expected to contribute to the growth of this market. The Diabetes Disposable Insulin Pen market research report delivers an acute valuation and taxonomy of the Diabetes Disposable Insulin Pen industry by practically splitting the market on the basis of different types, applications, and regions.
Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Diabetes Disposable Insulin Pen industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the Diabetes Disposable Insulin Pen industry is provided for the leading economies of the world.
The Diabetes Disposable Insulin Pen Market is segmented based on Type and Sales Channel. On the basis of type segmentation, the market is classified into Type 1 Diabetes and Type 2 Diabetes. In terms of Distribution Channel segmentation, the market is bifurcated into Hospitals, Clinics, Chemists, and Others.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 9.5 Billion |
Projected Market Size in 2026 |
USD 16.8 Billion |
CAGR Growth Rate |
5.2% CAGR |
Base Year |
2020 |
Forecast Years |
2020-2026 |
Key Market Players |
Health Care Center, P.B Pharmaceuticals, INJEX, Owen Mumford, Ltd., Nipro Medical Corporation, Novo Nordisk A/S, Berlin-Chemie Ag, Companion Medical, Pendiq Gmbh, Eli Lilly And Company, Emperra GmbH E-Health Technologies, Ypsomed Ag, Biocon, Sanofi, and others. |
Key Segment |
By Type, By Distribution Channel, By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the essential players operating in the Diabetes Disposable Insulin market include:
- Health Care Center
- P.B Pharmaceuticals
- INJEX
- Owen Mumford Ltd.
- Nipro Medical Corporation
- Novo Nordisk A/S
- Berlin-Chemie Ag
- Companion Medical
- Pendiq Gmbh
- Eli Lilly And Company
- Emperra GmbH E-Health Technologies
- Ypsomed Ag
- Biocon
- Sanofi
The taxonomy of the Diabetes Disposable Insulin Pen industry by its scope and segmentation is as follows:
By Type Segmentation Analysis (Customizable)
- Type 1 Diabetes
- Type 2 Diabetes
By Sales Channel Segmentation Analysis (Customizable)
- Hospitals
- Clinics
- Chemists
- Others
Regional Segmentation Analysis (Customizable)
- North America
- The U.S.
- Canada
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table of Content
Industry Major Market Players
- Health Care Center
- P.B Pharmaceuticals
- INJEX
- Owen Mumford Ltd.
- Nipro Medical Corporation
- Novo Nordisk A/S
- Berlin-Chemie Ag
- Companion Medical
- Pendiq Gmbh
- Eli Lilly And Company
- Emperra GmbH E-Health Technologies
- Ypsomed Ag
- Biocon
- Sanofi
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors